We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9988:HKEXAlibaba Group Holding Limited Analysis

Data as of 2026-05-26 - not real-time

HK$127.60

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Alibaba (9988.HK) trades at HK$127.6, well below its 20‑day (HK$131.9) and 50‑day (HK$129.7) SMAs, with a neutral RSI (44.7) and a bearish MACD histogram, suggesting short‑term pressure but ample room above the identified support of HK$124.3. Volatility remains high at 43% over the past 30 days, while the stock’s beta (≈0.6) indicates limited correlation to broader market moves, tempering systematic risk. Fundamentals show modest revenue growth (2.9%), a solid gross margin (≈40%), but thin operating margins (≈1%) and negative free cash flow, offset by a strong net‑cash position (cash HK$316B vs debt HK$282B). Valuation metrics point to upside: forward PE of 13.2, a dividend yield of 0.81% with a low payout ratio (17%), and analyst consensus (strong‑buy) targeting a median price of HK$182.7 – a 44% upside from current levels. The upcoming March‑quarter earnings release (May 13) and BNP Paribas’s new coverage highlighting accelerated cloud revenue provide a near‑term catalyst that could narrow the valuation gap.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Upcoming earnings release with cloud growth guidance
  • Technical support at HK$124.3 and increasing volume
  • Analyst consensus strong‑buy and sizable upside to target

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward earnings expansion reflected in forward PE 13.2
  • Continued cloud revenue acceleration
  • Valuation gap to median target price (~44% upside)

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong balance sheet with net cash position
  • Sustainable dividend yield and low payout ratio
  • Strategic position in e‑commerce and cloud across China and overseas

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin10.12%
P/E Ratio20.1
ROE9.22%
ROA2.12%
Debt/Equity25.01
P/B Ratio1.9
Op. Cash FlowHK$76.2B
Free Cash FlowHK$-44074250240

Technical Analysis

TrendNeutral
RSI44.7
SupportHK$124.30
ResistanceHK$144.00
MA 20HK$131.90
MA 50HK$129.72
MA 200HK$144.99
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair ValueHK$42.82
Target PriceHK$184.77
Upside/Downside44.80%
GradeUndervalued
TypeBlend
Dividend Yield0.81%

Risk Assessment

Beta0.64
Volatility43.07%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.